Home › Clinical investigation of rivaroxaban extended into important areas...
 

Keywords :   


Clinical investigation of rivaroxaban extended into important areas...

2014-09-02 16:45:54| Chemicals - Topix.net

Bayer HealthCare and its development partner Janssen Research & Development, LLC have announced an expansion of the global clinical development programme for the oral Factor Xa inhibitor, rivaroxaban, for the prevention of potentially deadly blood clots in patients at risk of venous and arterial thromboembolism : Rivaroxaban, Xarelto, has already ... (more)

Tags: important areas extended clinical

Category:Chemicals

Latest from this category

All news
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
21.11Sheboygan Paint Company Names New Customer Service Manager
Chemicals »
24.11 Beautiful World CD
24.11VIII
24.11PLUS MADHOUSE( ) 2
24.11KATO 10-1537 415
24.11125f-slim
24.11
24.11olend ona soft bag
24.1110ONKYO
More »